An FDA advisory committee unanimously recommended the agency approve two new antibiotics, while speakers debated the agency's approach to encouraging new drugs for drug-resistant infections.
from WSJ.com: US Business http://ift.tt/1fgEEXA
via IFTTT
from WSJ.com: US Business http://ift.tt/1fgEEXA
via IFTTT
No comments:
Post a Comment